MATSUI STATEMENT ON FDA FULL APPROVAL OF PFIZER-BIONTECH COVID-19 VACCINE

WASHINGTON, D.C., August 23, 2021 | George Hatamiya (916-201-5412)

WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (CA-06) issued the following statement after the FDA announced full approval of the Pfizer-BioNTech coronavirus vaccine.

“Vaccination remains the best tool we have to save lives and end the COVID-19 pandemic,” said Congresswoman Matsui. “The FDA’s full approval of the Pfizer-BioNTech COVID-19 vaccine is a crucial step forward to affirm what health care providers and public health experts have long known – the vaccine is safe and effective. Full approval is the culmination of intense scrutiny and a rigorous review process, and the FDA has never had more real-world evidence to inform this decision.”

“Full approval could not come at a more critical juncture,” Matsui continued. “As the Delta variant continues to infect Americans and drive up caseloads and hospitalizations across the country, we are in a race against time. Millions of Americans have already received COVID-19 vaccines, yet we must continue to increase vaccination rates to change the course of this pandemic. That is why it is vital that we continue to spread the message that getting vaccinated is safe, effective, and crucial to stop the spread in our communities and protect our children, our families, and ourselves.”

# # #